• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过 c-Met 和 Akt 抑制产生西妥昔单抗耐药性。

Inhibition of Generates Cetuximab Resistance through c-Met and Akt.

机构信息

Anorectal Surgery, Hwa Mei Hospital, University of Chinese Academy of Sciences, 41 Northwest Street Road, Haishu District, Ningbo 315800, China.

Ningbo Institute of Life and Health Industry, University of Chinese Academy of Sciences, 41 Northwest Street Road, Haishu District, Ningbo 315800, China.

出版信息

Biomed Res Int. 2020 Dec 8;2020:2046248. doi: 10.1155/2020/2046248. eCollection 2020.

DOI:10.1155/2020/2046248
PMID:33376716
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7744183/
Abstract

INTRODUCTION

Although cetuximab has been widely used in the treatment of colon cancer, a large number of patients eventually develop drug resistance. Therefore, it is essential to clarify the mechanism of drug resistance.

METHODS

In this study, we combined in silico analysis and a single guide RNA (sgRNA) library to locate cetuximab-sensitive genes. Cell proliferation, apoptosis, and cell cycle were assessed to validate the change in cetuximab sensitivity. Finally, western blotting was performed to detect changes in epidermal growth factor (EGFR) upstream and downstream genes.

RESULTS

Using in silico analysis and the sgRNA library, was confirmed as the cetuximab-sensitive gene. Further experiments indicated that the expression of could determine the level of cetuximab. Meanwhile, -inhibited cells were sensitive to mesenchymal epithelial transition factor (c-Met) and protein kinase B (Akt) inhibitors, which is related to the change in phosphorylation of c-Met and degradation of Akt.

CONCLUSION

modified the sensitivity to cetuximab through c-Met and Akt.

摘要

简介

虽然西妥昔单抗已被广泛用于治疗结肠癌,但大量患者最终会产生耐药性。因此,阐明耐药机制至关重要。

方法

本研究结合计算机分析和单向导 RNA(sgRNA)文库,定位西妥昔单抗敏感基因。通过细胞增殖、凋亡和细胞周期评估来验证西妥昔单抗敏感性的变化。最后,通过 Western blot 检测表皮生长因子(EGFR)上下游基因的变化。

结果

通过计算机分析和 sgRNA 文库, 被确认为西妥昔单抗敏感基因。进一步的实验表明, 的表达水平可以决定西妥昔单抗的疗效。同时, 抑制细胞对间质上皮转化因子(c-Met)和蛋白激酶 B(Akt)抑制剂敏感,这与 c-Met 磷酸化和 Akt 降解的变化有关。

结论

通过 c-Met 和 Akt 修饰对西妥昔单抗的敏感性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/762a/7744183/4a2b9ee34ede/BMRI2020-2046248.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/762a/7744183/88360bd055ad/BMRI2020-2046248.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/762a/7744183/7033513ba783/BMRI2020-2046248.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/762a/7744183/d85be52c123f/BMRI2020-2046248.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/762a/7744183/2b37b7f91523/BMRI2020-2046248.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/762a/7744183/4a2b9ee34ede/BMRI2020-2046248.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/762a/7744183/88360bd055ad/BMRI2020-2046248.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/762a/7744183/7033513ba783/BMRI2020-2046248.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/762a/7744183/d85be52c123f/BMRI2020-2046248.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/762a/7744183/2b37b7f91523/BMRI2020-2046248.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/762a/7744183/4a2b9ee34ede/BMRI2020-2046248.005.jpg

相似文献

1
Inhibition of Generates Cetuximab Resistance through c-Met and Akt.通过 c-Met 和 Akt 抑制产生西妥昔单抗耐药性。
Biomed Res Int. 2020 Dec 8;2020:2046248. doi: 10.1155/2020/2046248. eCollection 2020.
2
Increased TGF-α as a mechanism of acquired resistance to the anti-EGFR inhibitor cetuximab through EGFR-MET interaction and activation of MET signaling in colon cancer cells.TGF-α 增加是结肠癌细胞中获得性抗 EGFR 抑制剂西妥昔单抗耐药的机制,通过 EGFR-MET 相互作用和 MET 信号通路的激活。
Clin Cancer Res. 2013 Dec 15;19(24):6751-65. doi: 10.1158/1078-0432.CCR-13-0423. Epub 2013 Oct 11.
3
Exosomes promote cetuximab resistance via the PTEN/Akt pathway in colon cancer cells.外泌体通过PTEN/Akt信号通路促进结肠癌细胞对西妥昔单抗产生耐药性。
Braz J Med Biol Res. 2017 Nov 13;51(1):e6472. doi: 10.1590/1414-431X20176472.
4
Hepatocyte growth factor induces resistance to anti-epidermal growth factor receptor antibody in lung cancer.肝细胞生长因子诱导肺癌对表皮生长因子受体抗体的耐药性。
J Thorac Oncol. 2012 Feb;7(2):272-80. doi: 10.1097/JTO.0b013e3182398e69.
5
Cetuximab-induced MET activation acts as a novel resistance mechanism in colon cancer cells.西妥昔单抗诱导的MET激活在结肠癌细胞中作为一种新的耐药机制发挥作用。
Int J Mol Sci. 2014 Apr 4;15(4):5838-51. doi: 10.3390/ijms15045838.
6
HGF rescues colorectal cancer cells from EGFR inhibition via MET activation.HGF 通过激活 MET 拯救结直肠癌细胞免受 EGFR 抑制。
Clin Cancer Res. 2011 Feb 1;17(3):472-82. doi: 10.1158/1078-0432.CCR-10-0568. Epub 2010 Nov 22.
7
Cetuximab-resistant oral squamous cell carcinoma cells become sensitive in anchorage-independent culture conditions through the activation of the EGFR/AKT pathway.西妥昔单抗耐药的口腔鳞状细胞癌细胞在非贴壁培养条件下通过表皮生长因子受体/蛋白激酶B(EGFR/AKT)信号通路的激活而变得敏感。
Int J Oncol. 2015 Dec;47(6):2165-72. doi: 10.3892/ijo.2015.3215. Epub 2015 Oct 21.
8
Dacomitinib, an irreversible Pan-ErbB inhibitor significantly abrogates growth in head and neck cancer models that exhibit low response to cetuximab.达可替尼,一种不可逆的泛 ErbB 抑制剂,可显著抑制对西妥昔单抗反应较低的头颈部癌症模型的生长。
PLoS One. 2013;8(2):e56112. doi: 10.1371/journal.pone.0056112. Epub 2013 Feb 6.
9
Broad RTK-targeted therapy overcomes molecular heterogeneity-driven resistance to cetuximab via vectored immunoprophylaxis in colorectal cancer.广谱 RTK 靶向治疗通过载体免疫预防克服结直肠癌中分子异质性驱动的西妥昔单抗耐药性。
Cancer Lett. 2016 Nov 1;382(1):32-43. doi: 10.1016/j.canlet.2016.08.022. Epub 2016 Aug 26.
10
Novel toll-like receptor 9 agonist induces epidermal growth factor receptor (EGFR) inhibition and synergistic antitumor activity with EGFR inhibitors.新型Toll样受体9激动剂可诱导表皮生长因子受体(EGFR)抑制,并与EGFR抑制剂产生协同抗肿瘤活性。
Clin Cancer Res. 2006 Jan 15;12(2):577-83. doi: 10.1158/1078-0432.CCR-05-1943.

引用本文的文献

1
Involvement of Met receptor pathway in aggressive behavior of colorectal cancer cells induced by parathyroid hormone-related peptide.甲状旁腺素相关肽诱导的结直肠癌细胞侵袭行为中 Met 受体通路的参与。
World J Gastroenterol. 2022 Jul 14;28(26):3177-3200. doi: 10.3748/wjg.v28.i26.3177.
2
A Transcription Factor Signature Can Identify the CMS4 Subtype and Stratify the Prognostic Risk of Colorectal Cancer.一种转录因子特征可识别CMS4亚型并对结直肠癌的预后风险进行分层。
Front Oncol. 2022 Jun 30;12:902974. doi: 10.3389/fonc.2022.902974. eCollection 2022.

本文引用的文献

1
Dual EGFR blockade with cetuximab and erlotinib combined with anti-VEGF antibody bevacizumab in advanced solid tumors: a phase 1 dose escalation triplet combination trial.西妥昔单抗和厄洛替尼双重表皮生长因子受体(EGFR)阻断联合抗血管内皮生长因子(VEGF)抗体贝伐单抗用于晚期实体瘤:一项1期剂量递增三联组合试验
Exp Hematol Oncol. 2020 Apr 20;9:7. doi: 10.1186/s40164-020-00159-1. eCollection 2020.
2
Follow-up of low risk thyroid cancer patients: can we stop follow-up after 5 years of complete remission?低危甲状腺癌患者的随访:完全缓解 5 年后能否停止随访?
Eur J Endocrinol. 2020 May;182(5):D1-D16. doi: 10.1530/EJE-19-0960.
3
CCR7 high expression leads to cetuximab resistance by cross-talking with EGFR pathway in PI3K/AKT signals in colorectal cancer.
在结直肠癌中,CCR7高表达通过在PI3K/AKT信号中与EGFR通路相互作用导致西妥昔单抗耐药。
Am J Cancer Res. 2019 Nov 1;9(11):2531-2543. eCollection 2019.
4
VEGFR-1 Regulates EGF-R to Promote Proliferation in Colon Cancer Cells.VEGFR-1 通过调节 EGF-R 促进结肠癌细胞增殖。
Int J Mol Sci. 2019 Nov 9;20(22):5608. doi: 10.3390/ijms20225608.
5
Drug repurposing to overcome resistance to various therapies for colorectal cancer.药物再利用以克服结直肠癌对各种疗法的耐药性。
Cell Mol Life Sci. 2019 Sep;76(17):3383-3406. doi: 10.1007/s00018-019-03134-0. Epub 2019 May 13.
6
CEH-60/PBX and UNC-62/MEIS Coordinate a Metabolic Switch that Supports Reproduction in C. elegans.CEH-60/PBX 和 UNC-62/MEIS 协调代谢转换以支持秀丽隐杆线虫的繁殖。
Dev Cell. 2019 Apr 22;49(2):235-250.e7. doi: 10.1016/j.devcel.2019.03.002. Epub 2019 Apr 4.
7
Randomized phase II trial of cixutumumab alone or with cetuximab for refractory recurrent/metastatic head and neck squamous cell carcinoma.随机 II 期试验:西妥昔单抗单药或联合西妥昔单抗治疗难治性复发性/转移性头颈部鳞状细胞癌。
Oral Oncol. 2018 Jul;82:83-90. doi: 10.1016/j.oraloncology.2018.05.014. Epub 2018 May 19.
8
Expression of and in dipnoan and teleost fins provides new insights into the evolution of vertebrate appendages.在肺鱼和硬骨鱼鳍中[具体基因名称未给出]的表达为脊椎动物附肢的进化提供了新的见解。
Evodevo. 2018 Apr 27;9:11. doi: 10.1186/s13227-018-0099-9. eCollection 2018.
9
Genipin inhibits the invasion and migration of colon cancer cells by the suppression of HIF-1α accumulation and VEGF expression.栀子苷通过抑制 HIF-1α 积累和 VEGF 表达抑制结肠癌细胞的侵袭和迁移。
Food Chem Toxicol. 2018 Jun;116(Pt B):70-76. doi: 10.1016/j.fct.2018.04.005. Epub 2018 Apr 6.
10
Clinical Trials and Progress in Metastatic Colon Cancer.转移性结肠癌的临床试验与进展
Surg Oncol Clin N Am. 2018 Apr;27(2):349-365. doi: 10.1016/j.soc.2017.11.008.